Inactive Instrument

aXichem AB Stock Nasdaq Stockholm

SE0005250719

aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is an non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. As of December 31, 2011, the Company had such subsidiaries, as aXichem AB, aXimed AS, aXimed KH Limited and Guizhou aXimed Health Food Co Ltd. As of June 29, 2012, the Compantâ€™s two largest shareholders were Aximed AB (52.47%) and LMK Ventures AB (12.54%).

Employees

Sector

Specialty Chemicals

Calendar

26/11 Earnings release - Q3 2026

More about the company

Market Cap	117M 11.95M 10.35M 9.79M 8.86M 16.64M 1.15B 16.76M 44.95M 581M 44.9M 43.9M 1.85B	P/E 2024	-2.93x	P/E 2025	-6.9x
Enterprise Value	118M 12.12M 10.5M 9.93M 8.99M 16.87M 1.16B 17M 45.58M 590M 45.53M 44.52M 1.88B	EV / Sales 2024	7.67x	EV / Sales 2025	6.72x
Free-Float	82.56%	Yield 2024 *	-	Yield 2025	-

27/08	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
26/08	Calendar Thursday, August 27	FW
25/07	AXichem's Salmonella-inhibiting Chicken Feed Additive Gets EU Agency Backing	MT
26/06	AXichem Receives Order for Feed Additives for SEK4.2 Million	MT
17/06	Axichem AB Elects Michael Engstrom As Chairman Of The Board	RE
12/06	Calendar Monday June 15 - Friday June 19	FW
22/05	Calendar Friday May 22	FW
21/05	Axichem Q1 operating loss narrows to SEK 2.8 mln	RE
21/05	AXichem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Axichem proposes chairman	RE
07/05	Axichem launches axiphen ruminant in Brazil	RE
09/04	AXichem: Final study report shows aXiphen improves milk production	RE
18/03	Sweden's aXichem Secures Product Registration for Phenylcapsaicin Cattle Feed Additive in Brazil	MT

08/09	AXichem : notes growing commercial adoption in Brazil for aXiphen ruminant as Garra Nutrição increases volume to four tonnes	PU
24/08	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
24/08	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
24/07	AXichem : receives positive scientific opinion from EFSA for phenylcapsaicin as a salmonella-inhibiting additive in chicken feed	PU
26/06	AXichem : receives order for aXiphen from Chr. Olesen in Brazil to a value of SEK 4.2 million, for use in feed for chickens and ruminants	PU

Manager	Title	Age	Since
Nils Torsten Helsing CEO	Chief Executive Officer	69	01/01/2016
Erik Lager COO	Chief Operating Officer	51	16/04/2025
Gunilla Savring IRC	Investor Relations Contact	64	01/01/2015

Director	Title	Age	Since
Nils Torsten Helsing CHM	Chairman	69	06/07/2007
Jan-Ove Henry Gustavsson CHM	Chairman	80	01/01/2017
Jorn Havskov Berthelsen BRD	Director/Board Member	77	01/01/2017

aXichem AB Stock Nasdaq Stockholm

Stocks

SE0005250719

Specialty Chemicals

Valuation: aXichem AB

Latest news: aXichem AB

Press Releases: aXichem AB

Quotes and Performance

Managers and Directors: aXichem AB

Industrial Biotechnology Chemicals

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AXICHEM AB	-4.00%	+4.35%	-	-	12.76M
NOVONESIS A/S	-0.23%	-1.72%	+6.83%	+42.70%	30.89B
CATHAY BIOTECH INC.	-0.92%	-7.29%	-30.68%	-33.15%	4.07B
BORREGAARD ASA	-0.14%	-4.58%	-29.90%	-6.42%	1.56B
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	+2.47%	+2.82%	-7.78%	-12.85%	593M
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	+0.44%	-2.50%	-7.26%	-23.50%	592M
I-TECH AB	+1.39%	-0.95%	-23.63%	+90.81%	88.09M
SK MINERALS & ADDITIVES LIMITED	-1.34%	+2.03%	-	-	62.13M
Average	-0.29%	-0.74%	-15.40%	+9.60%	5.41B
Weighted average by Cap.	-0.25%	-2.02%	+0.76%	+30.72%

	2024	2025
Net sales	8.57M 877K 759K 718K 650K 1.22M 84.1M 1.23M 3.3M 42.65M 3.29M 3.22M 136M	18.45M 1.89M 1.63M 1.55M 1.4M 2.63M 181M 2.65M 7.1M 91.79M 7.09M 6.93M 293M
Net income	-17.81M -1.82M -1.58M -1.49M -1.35M -2.54M -175M -2.56M -6.85M -88.64M -6.85M -6.69M -283M	-17.63M -1.8M -1.56M -1.48M -1.34M -2.51M -173M -2.53M -6.78M -87.74M -6.78M -6.63M -280M
Net Debt	-14.36M -1.47M -1.27M -1.2M -1.09M -2.04M -141M -2.06M -5.52M -71.45M -5.52M -5.4M -228M	1.64M 168K 146K 138K 125K 234K 16.13M 236K 632K 8.18M 632K 618K 26.09M